MicroRNA-301a-3p suppressed the progression of hepatocellular carcinoma via targeting VGLL4

Torre, 2015, Global cancer statistics, 2012, CA. Cancer J. Clin., 65, 87, 10.3322/caac.21262 Sun, 2013, Adult-specific functions of animal microRNAs, Nat. Rev. Genet., 14, 535, 10.1038/nrg3471 Ambros, 2004, The functions of animal microRNAs, Nature, 431, 350, 10.1038/nature02871 Jansson, 2012, MicroRNA and cancer, Mol. Oncol., 6, 590, 10.1016/j.molonc.2012.09.006 Peng, 2016, The role of MicroRNAs in human cancer. Signal transduction and targeted therapy, Signal. Transduct. Target Ther., 1, 10.1038/sigtrans.2015.4 Mycko, 2012, MicroRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination, Proc. Natl. Acad. Sci. U. S. A., 109, E1248, 10.1073/pnas.1114325109 Ma, 2013, The expression and role of miR-301a in human umbilical cord-derived mesenchymal stromal cells, Cytotherapy, 15, 1511, 10.1016/j.jcyt.2013.06.007 He, 2016, miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-alpha in IBD, Gut, 65, 1938, 10.1136/gutjnl-2015-309389 Shi, 2011, MicroRNA-301 mediates proliferation and invasion in human breast cancer, Cancer Res., 71, 2926, 10.1158/0008-5472.CAN-10-3369 Cui, 2016, Expression of MicroRNA-301a and its functional roles in malignant melanoma, Cell. Physiol. Biochem., 40, 230, 10.1159/000452540 Xia, 2015, MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4, Oncotarget, 6, 21046, 10.18632/oncotarget.4124 Guo, 2013, A novel partner of scalloped regulates hippo signaling via antagonizing scalloped-yorkie activity, Cell Res., 23, 1201, 10.1038/cr.2013.120 Zhang, 2014, VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex, Cell Res., 24, 331, 10.1038/cr.2014.10 Jiao, 2014, A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer, Cancer Cell, 25, 166, 10.1016/j.ccr.2014.01.010 Lee, 2009, MicroRNAs in cancer, Ann. Rev. Pathol., 4, 199, 10.1146/annurev.pathol.4.110807.092222 Wang, 2013, Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer, J. Gastroenterol., 48, 1023, 10.1007/s00535-012-0733-6 Liu, 2013, The oncogenic role of microRNA-130a/301a/454 in human colorectal cancer via targeting Smad4 expression, PloS One, 8 Lu, 2011, miR-301a as an NF-kappaB activator in pancreatic cancer cells, EMBO J., 30, 57, 10.1038/emboj.2010.296 Wang, 2018, Hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN/PI3Kgamma to promote pancreatic cancer metastasis, Cancer Res., 78, 4586, 10.1158/0008-5472.CAN-17-3841 Lettlova, 2018, MiR-301a-3p suppresses estrogen signaling by directly inhibiting ESR1 in ERalpha positive breast cancer, Cell. Physiol. Biochem., 46, 2601, 10.1159/000489687 Lu, 2015, Hsa-miR-301a-3p acts as an oncogene in laryngeal squamous cell carcinoma via target regulation of Smad4, J. Cancer, 6, 1260, 10.7150/jca.12659 Jin, 2011, A novel inhibitor of apoptosis protein (IAP)-interacting protein, vestigial-like (Vgl)-4, counteracts apoptosis-inhibitory function of IAPs by nuclear sequestration, Biochem. Biophys. Res. Commun., 412, 454, 10.1016/j.bbrc.2011.07.117 Koontz, 2013, The hippo effector Yorkie controls normal tissue growth by antagonizing scalloped-mediated default repression, Dev. Cell., 25, 388, 10.1016/j.devcel.2013.04.021